心脉医疗股价连续3天上涨累计涨幅7.53%，新华基金旗下1只基金持2.47万股，浮盈赚取17.17万元

Group 1 - The core viewpoint of the news is that Xinmai Medical has seen a continuous increase in its stock price, with a 7.53% rise over three days, reaching 99.25 CNY per share, and a total market capitalization of 12.234 billion CNY [1] - Xinmai Medical, established on August 17, 2012, and listed on July 22, 2019, specializes in the research, production, and sales of interventional medical devices for aortic and peripheral blood vessels [1] - The company's main business revenue composition is as follows: 71.94% from aortic products, 28.04% from peripheral and other products, and 0.02% from other sources [1] Group 2 - According to data from the top ten holdings of funds, one fund under Xinhua Fund holds shares in Xinmai Medical, specifically the Xinhua Strategic Emerging Industries Flexible Allocation Mixed Fund (001294), which has maintained its holding of 24,700 shares [2] - The fund's holding represents 4.28% of its net asset value and is the eighth largest holding, with a floating profit of approximately 40,000 CNY today and 171,700 CNY during the three-day increase [2] - The Xinhua Strategic Emerging Industries Flexible Allocation Mixed Fund was established on June 29, 2015, with a latest scale of 52.9542 million CNY, and has achieved a year-to-date return of 3.07% [2]